Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA adsorbed to hydroxyapatite surfaces refers to a biomolecular-mineral complex rather than a discrete therapeutic target such as a receptor or enzyme. Hydroxyapatite (HAp), the primary inorganic constituent of human bone and teeth, possesses a high affinity for the negatively charged phosphate backbone of DNA, primarily through electrostatic interactions with calcium ions (C-sites) on the crystal surface (Okazaki et al., 2001; ScienceDirect). This interaction is a cornerstone of hydroxyapatite chromatography, a technique used to purify nucleic acids and proteins by exploiting their varying affinities for the mineral surface (Gorbunoff, 1984). In medical research, HAp-DNA complexes are extensively studied as non-viral vectors for gene therapy and bone tissue engineering, where the HAp serves as a biocompatible scaffold that protects DNA from enzymatic degradation and facilitates cellular uptake (Tofighi et al., 2005; Journal of Materials Chemistry). Furthermore, the adsorption of DNA to HAp is critical in forensic science and paleontology, as it explains the long-term preservation of genetic material within skeletal remains (Brundin et al., 2013). Because it describes a physical state or a delivery system rather than a biological molecule whose activity is modulated by drugs, it is not classified as a traditional drug target.
The complex functions as a delivery vehicle or purification medium where DNA phosphate groups adsorb to calcium sites on the hydroxyapatite surface via electrostatic interactions and coordination bonding (Gorbunoff, 1984; Okazaki et al., 2001).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA-hydroxyapatite complex (DNA-HAp).